Detalles de la búsqueda
1.
Hybrid Capture-Based Comprehensive Genomic Profiling Identifies Lung Cancer Patients with Well-Characterized Sensitizing Epidermal Growth Factor Receptor Point Mutations That Were Not Detected by Standard of Care Testing.
Oncologist
; 23(7): 776-781, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29540602
2.
A Phase II Study of the Combination of Bevacizumab, Pertuzumab, and Octreotide LAR for Patients with Advanced Neuroendocrine Cancers.
Cancer Invest
; 34(5): 213-9, 2016 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-27127841
Resultados
1 -
2
de 2
1
Próxima >
>>